Comment on “Effectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”

Available evidence suggests MeNZB™ is not associated with a durable effect against N. gonorrhoeae.

Bibliographic Details
Main Author: Chris Kenyon
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Vaccines
Subjects:
Online Access:http://www.mdpi.com/2076-393X/7/1/31